The patients with low-grade MDS also showed lower CD19 and CD38 expression, but they showed higher CD7, CD15, CD11b, CD4 and CD56 expression on CD34+ blasts in comparison to the patients with non-clonal cytopenia (all P<0.05). The gene discussed is NCAM1; the disease is myelodysplastic syndrome.